- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02372994
My Team of Care: a Pilot Randomized Controlled Trial of an Online Communication Tool for Collaborative Care (Loop)
August 15, 2016 updated by: Mount Sinai Hospital, Canada
My Team of Care (MyTOC) Trial: a Pilot Randomized Controlled Trial of an Online Communication Tool (Loop) for Collaborative Care in Complex Patients
This project will pilot and test a new online communication tool, Loop, developed within a research framework with participatory and user-centred design.
This pilot trial focuses on advanced cancer as an example of complex care.
Cancer care involves many healthcare providers, spanning hospital to home.
There is no organized way for them to communicate.
Loop is a practical tool for ongoing collaboration in the patient's actual team of care that engages patients.
The study will answer the questions: does Loop improve communication efficiency, engage patients and family physicians, and show early benefits in quality and health care costs?
Study Overview
Study Type
Interventional
Enrollment (Actual)
49
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5T 3L9
- Mount Sinai Hospital
-
Toronto, Ontario, Canada, M5T 2M9
- Princess Margaret Cancer Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients with Stage IV cancer, or Patients with stage III cancer and poor prognosis as determined by a physician (>3 months but <2 years)
- Eastern Cooperative Oncology Group (ECOG) performance status score ≤2
- Each patient must have at least two healthcare providers, including an attending oncologist or palliative care physician
- Patient and, if applicable, family caregiver must be ≥18 years of age
- Literacy and language capacity and competency to provide informed consent
- Patient or caregiver must have access to a computer and the internet
Exclusion Criteria:
- Patients without the capacity to participate in use of the online tool, and do not have a caregiver who can engage in use of the tool on their behalf
- Participants without the capacity to participate in evaluation of outcome measures, including, but not limited to, online and paper-based multiple-choice questions, checklists, and visual analogue scales, and do not have a family caregiver who can complete outcome measures
- A potential candidate for or currently receiving hormone therapy for breast or prostate cancer
- Patients with a prognosis of <3 months as determined by attending physician
- Patients with impaired mental status as previously assessed by a physician or judged by research staff using the Bedside Confusion Scale
- It has been determined that the patient is participating in another study precluding them from taking part in this study, as determined by an agreed-upon algorithm, tracked and managed by study coordinators
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention Group
The randomization is at the level of attending healthcare professional who identifies patients for recruitment.
For each participant in the intervention arm, a secure space (called a Patient Loop) is created in the online clinical communication system.
A Patient Loop can be accessed by the patient, their caregiver, and the healthcare providers who have permission to do so through an algorithm of invitation, authentication and careful partitioning.
In each Patient Loop, team members can post messages that can be read and responded to by the entire team.
Each Patient Loop consists of a patient, their caregiver and at least two healthcare professionals.
|
Loop is a secure online communication system centered on the patient that assembles the patient's actual healthcare team for ongoing collaborative care.
The patient and caregiver are integral members of the team.
Loop is cross-organizational, cross-setting and interprofessional.
It is for ongoing, interactive, contextual, team-based communication.
Loop is explicitly for asynchronous communication, not instant messaging.
The stream of messages is stored and can be sorted for ease of viewing.
The tool was developed with user-centred design and requires no prior training.
Other Names:
|
No Intervention: Control Group
Participants receive usual care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Trial feasibility measured with number of patients recruited for study who have consented and participate for the duration of the study.
Time Frame: 1 year
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Trial feasibility measured with number of healthcare providers recruited for study who have consented and participate for the duration of the study.
Time Frame: 1 year
|
1 year
|
|
Trial feasibility measured with number of family caregivers recruited for study who have consented and participate for the duration of the study.
Time Frame: 1 year
|
1 year
|
|
Palliative Care Outcomes Scale
Time Frame: 3 months
|
A 12 item questionnaire measuring patient-reported quality of care
|
3 months
|
Picker Ambulatory Cancer Care Survey Continuity and Coordination subscale
Time Frame: 3 months
|
An 8 item questionnaire measuring patient-perceived continuity and coordination of care
|
3 months
|
Ambulatory and Home Care Record
Time Frame: 3 months
|
Measure of ambulatory, home-based and acute care health services utilization, and associated public and private costs
|
3 months
|
Edmonton Symptom Assessment Scale
Time Frame: 3 months
|
A 10 item questionnaire measuring symptom intensity
|
3 months
|
Eastern Cooperative Oncology Group score
Time Frame: 3 months
|
A measure of performance status
|
3 months
|
The proportion of eligible participants who are invited to participate
Time Frame: 1 year
|
1 year
|
|
The proportion of invited participants who consent to participate
Time Frame: 1 year
|
1 year
|
|
The mean duration of participation of all study participants
Time Frame: 1 year
|
1 year
|
|
Instrument completion rate for the Palliative Care Outcomes Scale
Time Frame: 1 year
|
1 year
|
|
Item response rate for the Palliative Care Outcomes Scale
Time Frame: 1 year
|
1 year
|
|
Instrument completion rate for the Picker Ambulatory Cancer Care Survey Continuity and Coordination subscale
Time Frame: 1 year
|
1 year
|
|
Item response rate for the Picker Ambulatory Cancer Care Survey Continuity and Coordination subscale
Time Frame: 1 year
|
1 year
|
|
Instrument completion rate for the Ambulatory and Home Care Record
Time Frame: 1 year
|
1 year
|
|
Item response rate for the Ambulatory and Home Care Record
Time Frame: 1 year
|
1 year
|
|
Instrument completion rate for the Edmonton Symptom Assessment Scale
Time Frame: 1 year
|
1 year
|
|
Item response rate for the Edmonton Symptom Assessment Scale
Time Frame: 1 year
|
1 year
|
|
Number of family physicians who participate per study group
Time Frame: 1 year
|
1 year
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of posts per participant on the Loop system
Time Frame: 3 months
|
3 months
|
|
Number of times a patient logs into the Loop system
Time Frame: 3 months
|
3 months
|
|
Number of times a caregiver logs into the Loop system
Time Frame: 3 months
|
3 months
|
|
Number of times a healthcare provider logs into the Loop system
Time Frame: At end of study participation
|
Healthcare providers will be enrolled in the study for between 3 months and 1 year
|
At end of study participation
|
Time interval between a message posting by a patient/caregiver and a response by a healthcare provider on the Loop system
Time Frame: 3 months
|
3 months
|
|
Number of occurrences of user-reported errors
Time Frame: 3 months
|
3 months
|
|
Proportion of functions being used on the Loop system
Time Frame: 3 months
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Amna Husain, MD MPH, Temmy Latner Center for Palliative Care, Mount Sinai Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2015
Primary Completion (Actual)
April 1, 2016
Study Completion (Actual)
April 1, 2016
Study Registration Dates
First Submitted
January 26, 2015
First Submitted That Met QC Criteria
February 20, 2015
First Posted (Estimate)
February 26, 2015
Study Record Updates
Last Update Posted (Estimate)
August 16, 2016
Last Update Submitted That Met QC Criteria
August 15, 2016
Last Verified
August 1, 2016
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 410001734
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neoplasms
-
GlaxoSmithKlineCompleted
-
John M. BuattiNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedUterine Cervical Neoplasms | Prostatic Neoplasms | Rectal Neoplasms | Endometrial Neoplasms | Anus NeoplasmsUnited States
-
Amphia HospitalRecruitingColonic Neoplasms MalignantNetherlands
-
Marquette General Health SystemUpper Michigan Brain Tumor CenterWithdrawnGlioma | MeningiomaUnited States
-
European Association for Endoscopic SurgeryWithdrawn
-
GlaxoSmithKlineRecruitingColonic Neoplasms | Neoplasms, ColonUnited States, Finland, France, Italy, Japan, Netherlands, Norway, Spain, Taiwan, United Kingdom, Australia, Belgium, Brazil, Germany, Greece, Sweden, Turkey, Canada, Korea, Republic of, Argentina, Hungary, Estonia, Portugal, Mexico, Pa...
-
Ann & Robert H Lurie Children's Hospital of ChicagoCompletedBrain Stem Neoplasms, Primary | Neoplasms, Brain StemUnited States
-
Moscow Clinical Scientific CenterRecruitingCecal Neoplasms | Colonic Neoplasms MalignantRussian Federation
-
GlaxoSmithKlineRecruitingNeoplasms, RectalUnited States, France, Italy, Japan, Spain, United Kingdom, Germany, Korea, Republic of, Canada, Netherlands
-
Russian Society of Colorectal SurgeonsRecruitingNeoplasms,ColorectalRussian Federation
Clinical Trials on Loop
-
Inonu UniversityCompletedPancreatic FistulaTurkey
-
Stanford UniversityRecruitingParkinson DiseaseUnited States
-
Zagazig UniversityCompletedIatrogenic Bile Duct Injuries | Duodenojejunostomy Access LoopEgypt
-
University of MalayaNot yet recruitingARDS | Ventilator-Induced Lung Injury | Mechanical Ventilation Complication | Ventilator Lung
-
University of Texas at AustinRecruitingMild Cognitive ImpairmentUnited States
-
Liverpool John Moores UniversityAlder Hey Children's NHS Foundation TrustRecruitingObesity, AdolescentUnited Kingdom
-
Prasad Shirvalkar, MD, PhDNational Institute of Neurological Disorders and Stroke (NINDS); United States...Active, not recruitingChronic Pain | Spinal Cord Injuries | Phantom Limb Pain | Post Stroke PainUnited States
-
Stanford UniversityRecruiting
-
University of VirginiaDexCom, Inc.; Insulet Corporation; Abbott Diabetes Care; University of California...CompletedType 1 Diabetes MellitusUnited States
-
Azienda Ospedaliera Cardinale G. PanicoCompletedSyncope, Vasovagal, Neurally-MediatedItaly